ASSESSMENT OF CFTR CU SECRETION IN HUMAN COLON & EFFICACY OF F508DEL-CFTR CORRECTORS IN HUMAN NATIVE TISSUES

被引:0
|
作者
Sousa, M. [1 ,2 ]
Servidoni, M. D. [3 ]
Vinagre, A. M. [3 ]
Bonadia, L. [3 ]
Cardoso, S. R. [3 ]
Kmit, A. [3 ]
Ramalho, A. S. [1 ,2 ]
Bertuzzo, C. S. [3 ]
Ribeiro, A. F. [3 ]
Kunzelmann, K. [4 ]
Amaral, M. D. [1 ,2 ]
机构
[1] INSA, DG, Lisbon, Portugal
[2] FCUL, DQB, Lisbon, Portugal
[3] Univ Estadual Campinas, FCM, Campinas, Brazil
[4] UR, IP, Regensburg, Germany
关键词
CYSTIC-FIBROSIS; RESCUE;
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
引用
收藏
页码:300 / 301
页数:2
相关论文
共 50 条
  • [31] F508del-CFTR Rescue: A Matter of Cell Stress Response
    Nieddu, Erika
    Pollarolo, Benedetta
    Merello, Luisa
    Schenone, Silvia
    Mazzei, Mauro
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (19) : 3476 - 3496
  • [32] A Chemical Corrector Modifies the Channel Function of F508del-CFTR
    Chiaw, Patrick Kim
    Wellhauser, Leigh
    Huan, Ling Jun
    Ramjeesingh, Mohabir
    Bear, Christine E.
    MOLECULAR PHARMACOLOGY, 2010, 78 (03) : 411 - 418
  • [33] RETROSPECTIVE ANALYSIS OF PHYSIOLOGICAL RESPONSE PATTERNS TO TEZACAFTOR/IVACAFTOR IN PATIENTS WITH CYSTIC FIBROSIS HOMOZYGOUS FOR F508DEL-CFTR OR HETEROZYGOUS FOR F508DEL-CFTR AND A RESIDUAL FUNCTION MUTATION
    Ingenito, E.
    Nair, N.
    Yi, B.
    Lekstrom-Himes, J.
    Elborn, J.
    Rowe, S. M.
    PEDIATRIC PULMONOLOGY, 2018, 53 : 198 - 198
  • [34] RETROSPECTIVE ANALYSIS OF PHYSIOLOGICAL RESPONSE PATTERNS TO TEZACAFTOR/IVACAFTOR IN PATIENTS WITH CYSTIC FIBROSIS HOMOZYGOUS FOR F508DEL-CFTR OR HETEROZYGOUS FOR F508DEL-CFTR AND A RESIDUAL FUNCTION MUTATION
    Ingenito, E.
    Nair, N.
    Yi, B.
    Lekstrom-Himes, J.
    Elborn, J. S.
    Rowe, S. M.
    THORAX, 2018, 73 : A42 - A43
  • [35] A PRO-BIOGENESIS COMPLEX FOR F508DEL-CFTR DISCOVERED WITH A YEAST MODEL AND VALIDATED IN HUMAN CELLS
    Hong, J.
    Guo, J.
    Louie, R.
    Wen, H.
    Sorscher, E. J.
    Miller, E.
    Hartman, J. L.
    PEDIATRIC PULMONOLOGY, 2011, : 274 - 274
  • [36] S-Nitrosylation of CHIP Enhances F508Del-CFTR Maturation
    Zaman, Khalequz
    Knight, Julia
    Hussain, Faraaz
    Cao, Ruofan
    Estabrooks, Samuel K.
    Altawallbeh, Ghaith
    Holloway, Kristopher
    Jafri, Anjum
    Sawczak, Victoria
    Li, Yuejin
    Getsy, Paulina
    Sun, Fei
    Raffay, Thomas
    Cotton, Calvin
    Brodsky, Jeffrey L.
    Periasamy, Ammasi
    Lewis, Stephen J.
    Gaston, Benjamin
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2019, 61 (06) : 765 - 775
  • [37] EPIGENETIC REGULATION OF F508DEL-CFTR IN CYSTIC FIBROSIS LUNG DISEASE
    Kumar, P.
    Frizzell, R. A.
    Pollard, H.
    Biswas, R.
    PEDIATRIC PULMONOLOGY, 2017, 52 : S226 - S226
  • [38] Effects of Lumacaftor/Ivacaftor in a Pediatric Cohort Homozygous for F508del-CFTR
    Egan, Marie E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195 (07) : 849 - 850
  • [39] Unravelling druggable signalling networks that control F508del-CFTR proteostasis
    Hegde, Ramanath Narayana
    Parashuraman, Seetharaman
    Iorio, Francesco
    Ciciriello, Fabiana
    Capuani, Fabrizio
    Carissimo, Annamaria
    Carrella, Diego
    Belcastro, Vincenzo
    Subramanian, Advait
    Bounti, Laura
    Persico, Maria
    Carlile, Graeme
    Galietta, Luis
    Thomas, David Y.
    Di Bernardo, Diego
    Luini, Alberto
    ELIFE, 2015, 4
  • [40] Targeting the root cause of cystic fibrosis: rescuing F508del-CFTR
    Smith, Tanya A.
    Liu, Jia
    Kaura, Amit
    Sheppard, David N.
    SCOTTISH MEDICAL JOURNAL, 2014, 59 (01) : E31 - E31